Selected Publications


  • Sarayani A, Albogami Y, Elkhider M, Hincapie-Castillo JM, Brumback BA, Winterstein AG. Comparative effectiveness of risk mitigation strategies to prevent fetal exposure to mycophenolate. BMJ quality & safety. 2019 Oct 24:bmjqs-2019.
  • Li Y, Delcher C, Brown JD, Wei YJ, Reisfield GM, Winterstein AG. Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis. Drug and alcohol dependence. 2019 Sep 1;202:172-7.

News Release